“It’s what every physician should be using for a very easy and accessible way to look at a biomarker of longevity.” That biomarker is red blood cell distribution width (RDW) — an emerging measure linked to biological aging and resilience. As new science begins to quantify longevity, healthcare leaders are defining what it means in practice. Join Dr. Stephanie Venn-Watson, CEO & Co-founder of Fatty15, and other leaders at Fullscript Forward (Oct. 17, 12–3 p.m. EST) as they explore how to translat